| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Hemorrhage | 238 | 2025 | 2648 | 18.410 |
Why?
|
| Cerebral Amyloid Angiopathy | 78 | 2024 | 886 | 5.530 |
Why?
|
| Hematoma | 40 | 2023 | 766 | 4.550 |
Why?
|
| Stroke | 120 | 2024 | 9747 | 4.320 |
Why?
|
| Brain Ischemia | 56 | 2022 | 3000 | 3.140 |
Why?
|
| Cerebral Angiography | 25 | 2021 | 1262 | 2.010 |
Why?
|
| Leukoaraiosis | 13 | 2022 | 114 | 1.990 |
Why?
|
| Warfarin | 25 | 2017 | 1494 | 1.910 |
Why?
|
| Anticoagulants | 34 | 2023 | 4862 | 1.640 |
Why?
|
| Genetic Predisposition to Disease | 61 | 2024 | 18071 | 1.590 |
Why?
|
| Genome-Wide Association Study | 72 | 2024 | 12807 | 1.510 |
Why?
|
| Intracranial Hemorrhages | 14 | 2023 | 814 | 1.430 |
Why?
|
| Polymorphism, Single Nucleotide | 66 | 2023 | 16047 | 1.310 |
Why?
|
| Caregivers | 17 | 2022 | 2307 | 1.290 |
Why?
|
| Aged | 272 | 2025 | 171117 | 1.190 |
Why?
|
| Hypertension | 32 | 2025 | 8626 | 1.190 |
Why?
|
| Siderosis | 9 | 2023 | 100 | 1.190 |
Why?
|
| Brain | 58 | 2024 | 27171 | 1.160 |
Why?
|
| Apolipoprotein E4 | 12 | 2020 | 708 | 1.110 |
Why?
|
| Genetic Variation | 29 | 2024 | 6610 | 1.100 |
Why?
|
| Aged, 80 and over | 149 | 2025 | 59489 | 1.060 |
Why?
|
| Resilience, Psychological | 10 | 2020 | 806 | 1.060 |
Why?
|
| Apolipoproteins E | 21 | 2024 | 1458 | 1.020 |
Why?
|
| Humans | 461 | 2025 | 765968 | 1.000 |
Why?
|
| Middle Aged | 248 | 2025 | 223009 | 0.980 |
Why?
|
| Tomography, X-Ray Computed | 56 | 2023 | 20659 | 0.930 |
Why?
|
| Male | 307 | 2025 | 363698 | 0.930 |
Why?
|
| Hematoma, Subdural | 2 | 2024 | 128 | 0.920 |
Why?
|
| Intensive Care Units | 19 | 2022 | 3800 | 0.870 |
Why?
|
| Female | 304 | 2025 | 396112 | 0.870 |
Why?
|
| Magnetic Resonance Imaging | 105 | 2025 | 36532 | 0.840 |
Why?
|
| Leukoencephalopathies | 8 | 2022 | 259 | 0.830 |
Why?
|
| Recovery of Function | 16 | 2024 | 2966 | 0.830 |
Why?
|
| Cerebrovascular Disorders | 11 | 2020 | 1470 | 0.820 |
Why?
|
| Apolipoprotein E2 | 10 | 2019 | 133 | 0.800 |
Why?
|
| Family | 7 | 2021 | 3209 | 0.790 |
Why?
|
| Cerebellar Diseases | 4 | 2025 | 226 | 0.740 |
Why?
|
| Brain Edema | 7 | 2020 | 602 | 0.720 |
Why?
|
| Collagen Type IV | 5 | 2017 | 124 | 0.720 |
Why?
|
| Cerebral Arteries | 8 | 2017 | 490 | 0.720 |
Why?
|
| Brain Injuries | 6 | 2021 | 2060 | 0.690 |
Why?
|
| Depression | 22 | 2024 | 8237 | 0.690 |
Why?
|
| Blood Pressure | 19 | 2024 | 8532 | 0.680 |
Why?
|
| Atrial Fibrillation | 20 | 2023 | 5189 | 0.670 |
Why?
|
| Boxing | 1 | 2019 | 17 | 0.670 |
Why?
|
| Arteriolosclerosis | 1 | 2019 | 21 | 0.660 |
Why?
|
| Genotype | 46 | 2022 | 13024 | 0.660 |
Why?
|
| Critical Illness | 9 | 2021 | 2744 | 0.660 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 9 | 2022 | 3251 | 0.650 |
Why?
|
| Head | 2 | 2022 | 925 | 0.650 |
Why?
|
| Prospective Studies | 87 | 2024 | 54802 | 0.640 |
Why?
|
| Risk Factors | 109 | 2024 | 74840 | 0.630 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 3 | 2011 | 101 | 0.630 |
Why?
|
| Brain Diseases | 5 | 2019 | 1546 | 0.630 |
Why?
|
| Cohort Studies | 81 | 2024 | 41649 | 0.620 |
Why?
|
| Platelet Aggregation Inhibitors | 9 | 2019 | 2770 | 0.610 |
Why?
|
| Hospitals, Rural | 1 | 2020 | 175 | 0.610 |
Why?
|
| Drainage | 1 | 2024 | 1179 | 0.600 |
Why?
|
| Hospitals, Urban | 1 | 2020 | 493 | 0.590 |
Why?
|
| Genetic Association Studies | 13 | 2019 | 2741 | 0.590 |
Why?
|
| Survivors | 10 | 2022 | 2372 | 0.590 |
Why?
|
| Cerebral Cortex | 15 | 2019 | 5767 | 0.580 |
Why?
|
| Hemosiderosis | 4 | 2020 | 66 | 0.570 |
Why?
|
| Severity of Illness Index | 30 | 2024 | 15880 | 0.570 |
Why?
|
| Gene Frequency | 13 | 2019 | 3624 | 0.560 |
Why?
|
| Critical Care | 10 | 2019 | 2712 | 0.550 |
Why?
|
| Stress Disorders, Post-Traumatic | 10 | 2023 | 4628 | 0.530 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 2 | 2006 | 50 | 0.520 |
Why?
|
| Antihypertensive Agents | 8 | 2024 | 2033 | 0.520 |
Why?
|
| Longitudinal Studies | 34 | 2024 | 14751 | 0.520 |
Why?
|
| Patient Discharge | 8 | 2024 | 3461 | 0.520 |
Why?
|
| Genetic Loci | 12 | 2021 | 2631 | 0.500 |
Why?
|
| Nutritional Status | 1 | 2024 | 1620 | 0.500 |
Why?
|
| Adaptation, Psychological | 11 | 2022 | 2660 | 0.490 |
Why?
|
| Alleles | 13 | 2018 | 6897 | 0.490 |
Why?
|
| Hospital Mortality | 12 | 2020 | 5343 | 0.490 |
Why?
|
| Subarachnoid Hemorrhage | 7 | 2021 | 1022 | 0.480 |
Why?
|
| Anticonvulsants | 3 | 2015 | 1921 | 0.470 |
Why?
|
| Brain Stem Hemorrhage, Traumatic | 1 | 2014 | 13 | 0.470 |
Why?
|
| Urinary Tract Infections | 3 | 2018 | 805 | 0.470 |
Why?
|
| Lymphopenia | 1 | 2017 | 297 | 0.460 |
Why?
|
| Propylene Glycols | 1 | 2014 | 91 | 0.460 |
Why?
|
| Professional-Family Relations | 3 | 2021 | 501 | 0.450 |
Why?
|
| Cerebral Ventricles | 2 | 2019 | 549 | 0.450 |
Why?
|
| Recurrence | 21 | 2021 | 8501 | 0.450 |
Why?
|
| Myocardial Infarction | 9 | 2023 | 11499 | 0.440 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 3 | 2010 | 246 | 0.440 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2013 | 91 | 0.440 |
Why?
|
| Amyloid | 5 | 2022 | 853 | 0.440 |
Why?
|
| Retrospective Studies | 73 | 2025 | 81514 | 0.430 |
Why?
|
| Disease Progression | 28 | 2023 | 13632 | 0.430 |
Why?
|
| Nerve Fibers, Myelinated | 6 | 2013 | 952 | 0.430 |
Why?
|
| Research | 1 | 2022 | 1975 | 0.420 |
Why?
|
| Microvessels | 3 | 2017 | 591 | 0.420 |
Why?
|
| Imines | 1 | 2012 | 26 | 0.410 |
Why?
|
| Cerebral Infarction | 7 | 2018 | 970 | 0.410 |
Why?
|
| Glasgow Coma Scale | 13 | 2021 | 575 | 0.410 |
Why?
|
| Multivariate Analysis | 24 | 2020 | 12056 | 0.410 |
Why?
|
| Mendelian Randomization Analysis | 7 | 2023 | 1044 | 0.410 |
Why?
|
| Case-Control Studies | 37 | 2022 | 22223 | 0.400 |
Why?
|
| Sphingosine | 1 | 2014 | 306 | 0.400 |
Why?
|
| Brain Infarction | 5 | 2021 | 285 | 0.390 |
Why?
|
| Leukocyte Count | 1 | 2016 | 1602 | 0.390 |
Why?
|
| Receptor, PAR-1 | 1 | 2012 | 109 | 0.390 |
Why?
|
| Image Processing, Computer-Assisted | 23 | 2021 | 8923 | 0.390 |
Why?
|
| Cerebral Amyloid Angiopathy, Familial | 2 | 2023 | 53 | 0.390 |
Why?
|
| Receptors, Complement 3b | 1 | 2012 | 124 | 0.380 |
Why?
|
| Body Mass Index | 3 | 2024 | 13039 | 0.380 |
Why?
|
| Predictive Value of Tests | 31 | 2021 | 15398 | 0.380 |
Why?
|
| Decision Making | 4 | 2022 | 3965 | 0.370 |
Why?
|
| Catechol O-Methyltransferase | 4 | 2024 | 251 | 0.370 |
Why?
|
| Anxiety | 8 | 2022 | 4671 | 0.370 |
Why?
|
| Epilepsy | 4 | 2023 | 3320 | 0.370 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2010 | 533 | 0.370 |
Why?
|
| Nervous System Diseases | 5 | 2018 | 1660 | 0.370 |
Why?
|
| CADASIL | 4 | 2016 | 83 | 0.360 |
Why?
|
| Risk | 18 | 2019 | 9591 | 0.360 |
Why?
|
| Amyloid beta-Protein Precursor | 3 | 2017 | 1116 | 0.350 |
Why?
|
| Postoperative Hemorrhage | 1 | 2014 | 413 | 0.350 |
Why?
|
| Plasma | 6 | 2017 | 579 | 0.340 |
Why?
|
| Blood Loss, Surgical | 1 | 2014 | 629 | 0.340 |
Why?
|
| Lactones | 1 | 2012 | 316 | 0.340 |
Why?
|
| Prognosis | 39 | 2023 | 29922 | 0.340 |
Why?
|
| Hematoma, Subdural, Intracranial | 3 | 2017 | 30 | 0.340 |
Why?
|
| Cognition Disorders | 15 | 2017 | 3967 | 0.340 |
Why?
|
| Length of Stay | 7 | 2014 | 6485 | 0.330 |
Why?
|
| Principal Component Analysis | 4 | 2014 | 951 | 0.330 |
Why?
|
| Adult | 84 | 2024 | 223044 | 0.330 |
Why?
|
| Cerebral Arterial Diseases | 3 | 2019 | 82 | 0.330 |
Why?
|
| Personal Satisfaction | 1 | 2014 | 641 | 0.330 |
Why?
|
| Pneumonia | 3 | 2018 | 2157 | 0.320 |
Why?
|
| Mutation | 7 | 2023 | 30198 | 0.300 |
Why?
|
| Migraine without Aura | 2 | 2022 | 81 | 0.300 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 12 | 2022 | 2798 | 0.300 |
Why?
|
| Alzheimer Disease | 16 | 2023 | 8730 | 0.300 |
Why?
|
| Glutamic Acid | 1 | 2013 | 1180 | 0.290 |
Why?
|
| Genetic Testing | 4 | 2019 | 3595 | 0.290 |
Why?
|
| Vitamin K | 6 | 2017 | 312 | 0.290 |
Why?
|
| Blood Coagulation | 5 | 2019 | 1166 | 0.290 |
Why?
|
| Factor VIIa | 3 | 2007 | 102 | 0.290 |
Why?
|
| Atrophy | 4 | 2020 | 1635 | 0.280 |
Why?
|
| Genetics, Population | 2 | 2010 | 943 | 0.280 |
Why?
|
| Sex Factors | 13 | 2024 | 10603 | 0.280 |
Why?
|
| Brain Concussion | 5 | 2023 | 1432 | 0.280 |
Why?
|
| Erythrocyte Transfusion | 2 | 2013 | 568 | 0.280 |
Why?
|
| Logistic Models | 22 | 2021 | 13266 | 0.270 |
Why?
|
| Migraine with Aura | 2 | 2022 | 204 | 0.270 |
Why?
|
| International Normalized Ratio | 6 | 2017 | 381 | 0.270 |
Why?
|
| Thromboembolism | 3 | 2019 | 1003 | 0.270 |
Why?
|
| Aspirin | 5 | 2014 | 3134 | 0.270 |
Why?
|
| Comorbidity | 12 | 2020 | 10563 | 0.260 |
Why?
|
| Sepsis | 2 | 2018 | 2606 | 0.260 |
Why?
|
| Statistics, Nonparametric | 9 | 2017 | 2844 | 0.260 |
Why?
|
| Odds Ratio | 19 | 2021 | 9649 | 0.260 |
Why?
|
| Risk Assessment | 24 | 2023 | 24282 | 0.260 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2017 | 1426 | 0.260 |
Why?
|
| Ticlopidine | 1 | 2010 | 731 | 0.250 |
Why?
|
| Models, Cardiovascular | 1 | 2011 | 978 | 0.250 |
Why?
|
| Intracranial Hemorrhage, Hypertensive | 2 | 2017 | 19 | 0.250 |
Why?
|
| Connexin 43 | 2 | 2018 | 202 | 0.250 |
Why?
|
| Single-Blind Method | 3 | 2020 | 1589 | 0.240 |
Why?
|
| Intracranial Embolism | 3 | 2018 | 189 | 0.240 |
Why?
|
| Follow-Up Studies | 27 | 2024 | 39193 | 0.240 |
Why?
|
| Disability Evaluation | 4 | 2021 | 1820 | 0.240 |
Why?
|
| Nursing Staff, Hospital | 2 | 2019 | 350 | 0.240 |
Why?
|
| Europe | 10 | 2022 | 3423 | 0.240 |
Why?
|
| Linkage Disequilibrium | 6 | 2020 | 1997 | 0.240 |
Why?
|
| Neurology | 2 | 2019 | 785 | 0.240 |
Why?
|
| DNA, Mitochondrial | 1 | 2010 | 869 | 0.230 |
Why?
|
| Amyloid beta-Peptides | 8 | 2023 | 3896 | 0.230 |
Why?
|
| Phenotype | 18 | 2024 | 16721 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2018 | 416 | 0.230 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 3413 | 0.230 |
Why?
|
| Treatment Outcome | 34 | 2021 | 65188 | 0.230 |
Why?
|
| Blood Pressure Determination | 3 | 2017 | 647 | 0.230 |
Why?
|
| Arterial Occlusive Diseases | 4 | 2020 | 729 | 0.230 |
Why?
|
| Sex Characteristics | 4 | 2024 | 2643 | 0.220 |
Why?
|
| Blood Coagulation Factors | 3 | 2015 | 371 | 0.220 |
Why?
|
| Decision Support Techniques | 4 | 2009 | 2003 | 0.220 |
Why?
|
| Acute Disease | 8 | 2020 | 7232 | 0.220 |
Why?
|
| Data Collection | 6 | 2021 | 3318 | 0.220 |
Why?
|
| Intracranial Arteriosclerosis | 2 | 2016 | 137 | 0.210 |
Why?
|
| Nicardipine | 2 | 2021 | 59 | 0.210 |
Why?
|
| Time Factors | 17 | 2021 | 40065 | 0.210 |
Why?
|
| Epistasis, Genetic | 1 | 2005 | 353 | 0.210 |
Why?
|
| Semaphorins | 1 | 2023 | 96 | 0.210 |
Why?
|
| Anemia | 2 | 2011 | 1511 | 0.210 |
Why?
|
| Antifibrinolytic Agents | 4 | 2017 | 285 | 0.210 |
Why?
|
| Embolism | 2 | 2017 | 400 | 0.200 |
Why?
|
| Chemokine CXCL10 | 1 | 2023 | 310 | 0.200 |
Why?
|
| Proteins | 2 | 2015 | 5995 | 0.200 |
Why?
|
| Quality of Life | 8 | 2023 | 13462 | 0.200 |
Why?
|
| Hong Kong | 2 | 2021 | 169 | 0.200 |
Why?
|
| Models, Economic | 1 | 2006 | 716 | 0.200 |
Why?
|
| Stress, Psychological | 5 | 2024 | 4533 | 0.190 |
Why?
|
| Hypotension | 2 | 2018 | 885 | 0.190 |
Why?
|
| Quantitative Trait Loci | 7 | 2018 | 2140 | 0.190 |
Why?
|
| Life Style | 2 | 2024 | 3926 | 0.190 |
Why?
|
| Genomics | 5 | 2024 | 5929 | 0.190 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 4209 | 0.190 |
Why?
|
| Dementia | 3 | 2024 | 2744 | 0.190 |
Why?
|
| Thalamus | 2 | 2021 | 1048 | 0.180 |
Why?
|
| Oxidative Phosphorylation | 2 | 2014 | 502 | 0.180 |
Why?
|
| Mannose-Binding Lectin | 1 | 2022 | 146 | 0.180 |
Why?
|
| Gene Dosage | 2 | 2019 | 1216 | 0.180 |
Why?
|
| Pyridines | 1 | 2012 | 2888 | 0.180 |
Why?
|
| Family Relations | 2 | 2019 | 318 | 0.180 |
Why?
|
| Fibrinolytic Agents | 5 | 2023 | 2080 | 0.170 |
Why?
|
| Intracranial Pressure | 3 | 2010 | 322 | 0.170 |
Why?
|
| Calcium | 3 | 2019 | 5767 | 0.170 |
Why?
|
| Homocysteine | 4 | 2015 | 638 | 0.170 |
Why?
|
| Memory | 4 | 2017 | 2190 | 0.170 |
Why?
|
| Disease Management | 2 | 2024 | 2535 | 0.170 |
Why?
|
| Electroencephalography | 5 | 2023 | 6273 | 0.170 |
Why?
|
| Aniline Compounds | 5 | 2022 | 1075 | 0.160 |
Why?
|
| Communication | 1 | 2014 | 3916 | 0.160 |
Why?
|
| Patient Transfer | 2 | 2019 | 790 | 0.160 |
Why?
|
| Incidental Findings | 1 | 2004 | 697 | 0.160 |
Why?
|
| Age Factors | 8 | 2019 | 18380 | 0.160 |
Why?
|
| Hospital Bed Capacity | 1 | 2020 | 200 | 0.160 |
Why?
|
| Sleep | 4 | 2023 | 4813 | 0.160 |
Why?
|
| Blood Coagulation Disorders, Inherited | 1 | 2019 | 19 | 0.160 |
Why?
|
| Brain Waves | 1 | 2023 | 417 | 0.160 |
Why?
|
| Atherosclerosis | 3 | 2023 | 3424 | 0.160 |
Why?
|
| Quality of Health Care | 1 | 2014 | 4300 | 0.160 |
Why?
|
| Blood Transfusion | 1 | 2005 | 1297 | 0.160 |
Why?
|
| Hemorrhage | 4 | 2009 | 3461 | 0.150 |
Why?
|
| Cognition | 5 | 2023 | 7049 | 0.150 |
Why?
|
| Tomography Scanners, X-Ray Computed | 2 | 2016 | 170 | 0.150 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2019 | 113 | 0.150 |
Why?
|
| Radiography | 7 | 2014 | 6919 | 0.150 |
Why?
|
| Models, Genetic | 5 | 2018 | 3449 | 0.150 |
Why?
|
| Aphasia | 1 | 2020 | 191 | 0.150 |
Why?
|
| Patient Admission | 4 | 2019 | 1365 | 0.150 |
Why?
|
| Survival Analysis | 7 | 2023 | 10070 | 0.150 |
Why?
|
| Post-Concussion Syndrome | 1 | 2021 | 257 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 2010 | 378 | 0.150 |
Why?
|
| Markov Chains | 4 | 2009 | 968 | 0.140 |
Why?
|
| Incidence | 10 | 2024 | 21480 | 0.140 |
Why?
|
| Phenformin | 1 | 1997 | 15 | 0.140 |
Why?
|
| Trauma, Nervous System | 1 | 2017 | 35 | 0.140 |
Why?
|
| Malnutrition | 1 | 2024 | 629 | 0.140 |
Why?
|
| Prevalence | 13 | 2023 | 15842 | 0.140 |
Why?
|
| Neurosciences | 2 | 2019 | 385 | 0.140 |
Why?
|
| Encephalitis, Tick-Borne | 1 | 2018 | 45 | 0.140 |
Why?
|
| Encephalitis Viruses, Tick-Borne | 1 | 2018 | 48 | 0.140 |
Why?
|
| Chaplaincy Service, Hospital | 1 | 2017 | 22 | 0.140 |
Why?
|
| Reproducibility of Results | 17 | 2018 | 20124 | 0.140 |
Why?
|
| Ischemic Attack, Transient | 2 | 2014 | 870 | 0.140 |
Why?
|
| Subarachnoid Space | 1 | 2017 | 77 | 0.140 |
Why?
|
| Object Attachment | 1 | 2020 | 329 | 0.140 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2007 | 4034 | 0.140 |
Why?
|
| Factor VIII | 1 | 2019 | 347 | 0.130 |
Why?
|
| Genome, Human | 4 | 2014 | 4448 | 0.130 |
Why?
|
| Amyloidosis | 2 | 2022 | 885 | 0.130 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 2 | 2006 | 20 | 0.130 |
Why?
|
| Proportional Hazards Models | 12 | 2024 | 12509 | 0.130 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 2 | 2006 | 42 | 0.130 |
Why?
|
| Secondary Prevention | 3 | 2024 | 1472 | 0.130 |
Why?
|
| Hypoalbuminemia | 1 | 2017 | 90 | 0.130 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2020 | 1167 | 0.130 |
Why?
|
| Pastoral Care | 1 | 2017 | 72 | 0.130 |
Why?
|
| Brain Stem | 1 | 2021 | 853 | 0.130 |
Why?
|
| Factor VII | 2 | 2007 | 139 | 0.130 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2016 | 276 | 0.130 |
Why?
|
| Survival Rate | 7 | 2021 | 12795 | 0.130 |
Why?
|
| Hypernatremia | 1 | 2016 | 78 | 0.130 |
Why?
|
| Aftercare | 2 | 2021 | 911 | 0.130 |
Why?
|
| Acidosis, Lactic | 1 | 1997 | 144 | 0.130 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2016 | 111 | 0.130 |
Why?
|
| Age of Onset | 4 | 2017 | 3344 | 0.130 |
Why?
|
| Craniotomy | 1 | 2020 | 730 | 0.120 |
Why?
|
| Coronary Artery Disease | 7 | 2023 | 6544 | 0.120 |
Why?
|
| Electrocardiography | 4 | 2018 | 6404 | 0.120 |
Why?
|
| Carotid Artery Diseases | 1 | 2022 | 874 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2017 | 340 | 0.120 |
Why?
|
| Urine | 1 | 2017 | 360 | 0.120 |
Why?
|
| United States | 19 | 2023 | 72903 | 0.120 |
Why?
|
| Magnesium | 1 | 2019 | 813 | 0.120 |
Why?
|
| Hyperlipidemias | 2 | 2010 | 770 | 0.120 |
Why?
|
| Pons | 1 | 2016 | 238 | 0.120 |
Why?
|
| Angiopoietin-1 | 1 | 2015 | 132 | 0.120 |
Why?
|
| Genetic Markers | 4 | 2022 | 2601 | 0.120 |
Why?
|
| Interpersonal Relations | 2 | 2020 | 1432 | 0.120 |
Why?
|
| Hypocalcemia | 1 | 2016 | 205 | 0.120 |
Why?
|
| Synapses | 1 | 2024 | 1754 | 0.120 |
Why?
|
| Image Interpretation, Computer-Assisted | 5 | 2014 | 3356 | 0.120 |
Why?
|
| von Willebrand Factor | 1 | 2019 | 676 | 0.120 |
Why?
|
| Neuroradiography | 1 | 2015 | 71 | 0.120 |
Why?
|
| Leukocytosis | 1 | 2016 | 248 | 0.120 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2014 | 45 | 0.120 |
Why?
|
| Zinc Fingers | 1 | 2017 | 576 | 0.120 |
Why?
|
| Thiazoles | 4 | 2013 | 1529 | 0.120 |
Why?
|
| Drug Discovery | 1 | 2022 | 1064 | 0.120 |
Why?
|
| Registries | 4 | 2019 | 8297 | 0.120 |
Why?
|
| Post-Exposure Prophylaxis | 1 | 2015 | 113 | 0.110 |
Why?
|
| Causality | 4 | 2010 | 1248 | 0.110 |
Why?
|
| Peroxidase | 1 | 2017 | 606 | 0.110 |
Why?
|
| Verbal Learning | 1 | 2016 | 461 | 0.110 |
Why?
|
| Cholesterol, LDL | 2 | 2022 | 2393 | 0.110 |
Why?
|
| Blood | 1 | 2017 | 597 | 0.110 |
Why?
|
| Sputum | 1 | 2017 | 513 | 0.110 |
Why?
|
| Deglutition Disorders | 1 | 2020 | 639 | 0.110 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2016 | 471 | 0.110 |
Why?
|
| Metagenomics | 1 | 2018 | 473 | 0.110 |
Why?
|
| Pilot Projects | 4 | 2021 | 8733 | 0.110 |
Why?
|
| Sensitivity and Specificity | 11 | 2021 | 14652 | 0.110 |
Why?
|
| Interleukin-6 | 1 | 2023 | 3222 | 0.110 |
Why?
|
| Serum Albumin | 1 | 2017 | 675 | 0.110 |
Why?
|
| Medical Staff, Hospital | 1 | 2017 | 601 | 0.110 |
Why?
|
| Brain Neoplasms | 3 | 2020 | 9071 | 0.110 |
Why?
|
| Hydrocephalus | 1 | 2020 | 762 | 0.110 |
Why?
|
| Judgment | 1 | 2015 | 270 | 0.110 |
Why?
|
| Cerebrovascular Circulation | 5 | 2020 | 2674 | 0.110 |
Why?
|
| Linear Models | 7 | 2019 | 5876 | 0.110 |
Why?
|
| Clinical Trials as Topic | 4 | 2017 | 8041 | 0.110 |
Why?
|
| Physicians | 1 | 2011 | 4588 | 0.110 |
Why?
|
| Receptors, Dopamine | 1 | 2014 | 291 | 0.110 |
Why?
|
| Unnecessary Procedures | 1 | 2017 | 416 | 0.110 |
Why?
|
| Ischemia | 2 | 2019 | 1909 | 0.110 |
Why?
|
| Depressive Disorder, Major | 2 | 2023 | 4808 | 0.110 |
Why?
|
| Bayes Theorem | 4 | 2022 | 2354 | 0.110 |
Why?
|
| Long QT Syndrome | 1 | 2018 | 474 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2014 | 430 | 0.100 |
Why?
|
| Activities of Daily Living | 4 | 2021 | 2415 | 0.100 |
Why?
|
| Heart Conduction System | 1 | 2018 | 1006 | 0.100 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 1394 | 0.100 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 2013 | 59 | 0.100 |
Why?
|
| Electron Transport Complex I | 1 | 2014 | 151 | 0.100 |
Why?
|
| Cyclooxygenase 2 | 1 | 2015 | 594 | 0.100 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2014 | 216 | 0.100 |
Why?
|
| Databases, Nucleic Acid | 1 | 2013 | 204 | 0.100 |
Why?
|
| Triglycerides | 2 | 2020 | 2441 | 0.100 |
Why?
|
| Repressor Proteins | 2 | 2014 | 2968 | 0.100 |
Why?
|
| C-Reactive Protein | 1 | 2024 | 3850 | 0.100 |
Why?
|
| Glasgow Outcome Scale | 3 | 2021 | 102 | 0.100 |
Why?
|
| Electronic Health Records | 3 | 2024 | 4873 | 0.100 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2013 | 135 | 0.100 |
Why?
|
| Family Health | 1 | 2017 | 1253 | 0.100 |
Why?
|
| Hospitals, University | 1 | 2014 | 574 | 0.100 |
Why?
|
| Cyclonic Storms | 1 | 2013 | 121 | 0.100 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2014 | 412 | 0.100 |
Why?
|
| T-Box Domain Proteins | 1 | 2014 | 469 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2014 | 640 | 0.090 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2024 | 605 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2017 | 6499 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2012 | 371 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 1740 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2012 | 311 | 0.090 |
Why?
|
| Hematologic Neoplasms | 1 | 2023 | 1927 | 0.090 |
Why?
|
| Tidal Volume | 1 | 2013 | 519 | 0.090 |
Why?
|
| Subtraction Technique | 1 | 2014 | 512 | 0.090 |
Why?
|
| Databases, Factual | 4 | 2017 | 8067 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 4 | 2015 | 2686 | 0.090 |
Why?
|
| Adolescent | 17 | 2022 | 88835 | 0.090 |
Why?
|
| Genes, Mitochondrial | 1 | 2010 | 59 | 0.090 |
Why?
|
| Basal Ganglia | 1 | 2013 | 549 | 0.090 |
Why?
|
| Receptors, Notch | 1 | 2015 | 752 | 0.090 |
Why?
|
| Tomography, Spiral Computed | 1 | 2012 | 273 | 0.090 |
Why?
|
| ABO Blood-Group System | 1 | 2013 | 380 | 0.090 |
Why?
|
| Neuropsychological Tests | 7 | 2021 | 7123 | 0.090 |
Why?
|
| Young Adult | 14 | 2020 | 59889 | 0.090 |
Why?
|
| Memory Disorders | 1 | 2017 | 1194 | 0.090 |
Why?
|
| Specimen Handling | 1 | 2014 | 704 | 0.080 |
Why?
|
| Regression Analysis | 6 | 2017 | 6322 | 0.080 |
Why?
|
| Diffusion Tensor Imaging | 5 | 2024 | 2410 | 0.080 |
Why?
|
| Uric Acid | 1 | 2016 | 809 | 0.080 |
Why?
|
| Hematocrit | 1 | 2011 | 621 | 0.080 |
Why?
|
| Biomedical Technology | 1 | 2012 | 210 | 0.080 |
Why?
|
| Seizures | 3 | 2023 | 3000 | 0.080 |
Why?
|
| Autopsy | 2 | 2012 | 1011 | 0.080 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2010 | 139 | 0.080 |
Why?
|
| Venous Thromboembolism | 1 | 2022 | 1882 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5302 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2022 | 10383 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 2019 | 1327 | 0.080 |
Why?
|
| Confidence Intervals | 2 | 2012 | 2910 | 0.080 |
Why?
|
| Population Groups | 1 | 2010 | 209 | 0.080 |
Why?
|
| Ear Canal | 1 | 2010 | 149 | 0.080 |
Why?
|
| Mental Health | 1 | 2023 | 3278 | 0.080 |
Why?
|
| Genes | 1 | 2013 | 1825 | 0.080 |
Why?
|
| Research Design | 3 | 2024 | 6209 | 0.080 |
Why?
|
| Delayed Diagnosis | 1 | 2012 | 452 | 0.080 |
Why?
|
| Cross-Sectional Studies | 11 | 2021 | 26318 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 2709 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 1509 | 0.080 |
Why?
|
| Posterior Cerebral Artery | 1 | 2008 | 34 | 0.080 |
Why?
|
| Neurosurgical Procedures | 1 | 2019 | 2074 | 0.080 |
Why?
|
| Positive-Pressure Respiration | 1 | 2013 | 711 | 0.080 |
Why?
|
| Interdisciplinary Communication | 1 | 2014 | 932 | 0.070 |
Why?
|
| Chromosome Mapping | 4 | 2014 | 4618 | 0.070 |
Why?
|
| Calcinosis | 1 | 2017 | 1479 | 0.070 |
Why?
|
| Neuronal Plasticity | 1 | 2016 | 1445 | 0.070 |
Why?
|
| Nuclear Proteins | 2 | 2014 | 5783 | 0.070 |
Why?
|
| Pattern Recognition, Automated | 1 | 2014 | 978 | 0.070 |
Why?
|
| Mixed Function Oxygenases | 1 | 2009 | 265 | 0.070 |
Why?
|
| Disasters | 1 | 2013 | 520 | 0.070 |
Why?
|
| Histone Deacetylases | 1 | 2012 | 708 | 0.070 |
Why?
|
| Polymorphism, Genetic | 2 | 2016 | 4247 | 0.070 |
Why?
|
| Perception | 1 | 2014 | 1205 | 0.070 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2009 | 1737 | 0.070 |
Why?
|
| Women's Health | 1 | 2017 | 2084 | 0.070 |
Why?
|
| Cholesterol | 1 | 2016 | 2898 | 0.070 |
Why?
|
| Haplotypes | 3 | 2010 | 2728 | 0.070 |
Why?
|
| Emergency Service, Hospital | 5 | 2019 | 7875 | 0.070 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2012 | 1224 | 0.070 |
Why?
|
| Neural Pathways | 2 | 2014 | 3085 | 0.070 |
Why?
|
| Positron-Emission Tomography | 5 | 2022 | 6547 | 0.070 |
Why?
|
| Neocortex | 1 | 2010 | 414 | 0.070 |
Why?
|
| Monocytes | 1 | 2016 | 2595 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2017 | 2590 | 0.070 |
Why?
|
| Taurine | 1 | 2006 | 91 | 0.070 |
Why?
|
| GABA Agonists | 1 | 2006 | 105 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 3 | 2019 | 1370 | 0.060 |
Why?
|
| Thrombophilia | 1 | 2008 | 308 | 0.060 |
Why?
|
| Posture | 1 | 2010 | 954 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2012 | 4108 | 0.060 |
Why?
|
| Heart Rate | 1 | 2017 | 4204 | 0.060 |
Why?
|
| Hospitalization | 4 | 2022 | 10808 | 0.060 |
Why?
|
| Fatigue | 2 | 2023 | 1549 | 0.060 |
Why?
|
| Myocardium | 1 | 2018 | 4760 | 0.060 |
Why?
|
| Organ Size | 3 | 2020 | 2260 | 0.060 |
Why?
|
| Osmotic Pressure | 1 | 2005 | 136 | 0.060 |
Why?
|
| Models, Neurological | 3 | 2022 | 1747 | 0.060 |
Why?
|
| Aging | 4 | 2011 | 8731 | 0.060 |
Why?
|
| Observer Variation | 3 | 2019 | 2615 | 0.060 |
Why?
|
| Life Change Events | 2 | 2023 | 954 | 0.060 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 2428 | 0.060 |
Why?
|
| Neoplasms | 3 | 2019 | 22340 | 0.060 |
Why?
|
| Hospitals | 3 | 2021 | 3888 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 1892 | 0.060 |
Why?
|
| Hemosiderin | 1 | 2004 | 40 | 0.060 |
Why?
|
| Exons | 1 | 2010 | 2391 | 0.060 |
Why?
|
| Kidney | 1 | 2020 | 7066 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2019 | 9347 | 0.060 |
Why?
|
| Administration, Oral | 3 | 2022 | 4015 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 1997 | 3110 | 0.060 |
Why?
|
| Valine | 2 | 2016 | 410 | 0.060 |
Why?
|
| Life Tables | 1 | 2004 | 363 | 0.060 |
Why?
|
| Nerve Net | 1 | 2016 | 2309 | 0.060 |
Why?
|
| Child Abuse | 1 | 2013 | 1090 | 0.060 |
Why?
|
| Self Efficacy | 2 | 2020 | 642 | 0.060 |
Why?
|
| International Cooperation | 1 | 2010 | 1432 | 0.060 |
Why?
|
| Internet | 2 | 2013 | 3106 | 0.050 |
Why?
|
| Methionine | 2 | 2016 | 569 | 0.050 |
Why?
|
| Genetic Counseling | 1 | 2007 | 634 | 0.050 |
Why?
|
| Oxidative Stress | 2 | 2012 | 3141 | 0.050 |
Why?
|
| Monitoring, Physiologic | 2 | 2018 | 1792 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2019 | 3785 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2012 | 13400 | 0.050 |
Why?
|
| Neutrophils | 1 | 2016 | 3776 | 0.050 |
Why?
|
| Basilar Artery | 2 | 2019 | 206 | 0.050 |
Why?
|
| Central Nervous System Infections | 1 | 2004 | 61 | 0.050 |
Why?
|
| Geriatric Psychiatry | 1 | 2023 | 70 | 0.050 |
Why?
|
| Multifactorial Inheritance | 2 | 2022 | 1425 | 0.050 |
Why?
|
| Boston | 4 | 2017 | 9338 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 6069 | 0.050 |
Why?
|
| Vasculitis | 1 | 2007 | 527 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2015 | 4427 | 0.050 |
Why?
|
| Suicidal Ideation | 1 | 2013 | 1461 | 0.050 |
Why?
|
| Myocardial Ischemia | 2 | 2011 | 2128 | 0.050 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2002 | 62 | 0.050 |
Why?
|
| Palliative Care | 1 | 2017 | 3645 | 0.050 |
Why?
|
| Kentucky | 1 | 2002 | 83 | 0.050 |
Why?
|
| Patient Selection | 2 | 2019 | 4255 | 0.050 |
Why?
|
| Clusterin | 1 | 2022 | 71 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 3430 | 0.050 |
Why?
|
| Algorithms | 5 | 2019 | 14071 | 0.050 |
Why?
|
| Hyperhomocysteinemia | 1 | 2002 | 117 | 0.050 |
Why?
|
| Early Diagnosis | 1 | 2007 | 1187 | 0.050 |
Why?
|
| Cholesterol, HDL | 2 | 2020 | 1811 | 0.050 |
Why?
|
| Corpus Callosum | 2 | 2022 | 751 | 0.050 |
Why?
|
| Ohio | 1 | 2002 | 320 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2016 | 5912 | 0.050 |
Why?
|
| Thrombolytic Therapy | 1 | 2010 | 2059 | 0.050 |
Why?
|
| American Heart Association | 2 | 2017 | 1047 | 0.050 |
Why?
|
| Child Development | 1 | 2013 | 2327 | 0.050 |
Why?
|
| Catheters, Indwelling | 1 | 2004 | 438 | 0.050 |
Why?
|
| Syndrome | 1 | 2007 | 3271 | 0.050 |
Why?
|
| Amyloidogenic Proteins | 1 | 2022 | 153 | 0.050 |
Why?
|
| Selection, Genetic | 1 | 2005 | 878 | 0.040 |
Why?
|
| Problem Solving | 1 | 2023 | 440 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2004 | 952 | 0.040 |
Why?
|
| RNA | 1 | 2010 | 2717 | 0.040 |
Why?
|
| Peptide Fragments | 2 | 2006 | 5125 | 0.040 |
Why?
|
| Valproic Acid | 1 | 2023 | 445 | 0.040 |
Why?
|
| Embolism, Cholesterol | 1 | 2000 | 33 | 0.040 |
Why?
|
| Africa | 1 | 2022 | 725 | 0.040 |
Why?
|
| Cost of Illness | 2 | 2022 | 1950 | 0.040 |
Why?
|
| Angiography | 1 | 2005 | 1581 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 2796 | 0.040 |
Why?
|
| Antidepressive Agents | 2 | 2022 | 2897 | 0.040 |
Why?
|
| Diagnosis, Differential | 5 | 2016 | 12976 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 2900 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 3432 | 0.040 |
Why?
|
| Obesity | 2 | 2020 | 13076 | 0.040 |
Why?
|
| Inflammation | 2 | 2017 | 10850 | 0.040 |
Why?
|
| Child | 9 | 2023 | 80564 | 0.040 |
Why?
|
| ROC Curve | 2 | 2021 | 3620 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2018 | 3797 | 0.040 |
Why?
|
| Apolipoprotein E3 | 1 | 2019 | 105 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2004 | 855 | 0.040 |
Why?
|
| Haptoglobins | 1 | 2020 | 166 | 0.040 |
Why?
|
| Brain Mapping | 4 | 2021 | 6601 | 0.040 |
Why?
|
| Vertebral Artery | 1 | 2019 | 184 | 0.040 |
Why?
|
| Persistent Vegetative State | 1 | 2021 | 274 | 0.040 |
Why?
|
| Waist-Hip Ratio | 1 | 2020 | 520 | 0.040 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2004 | 644 | 0.040 |
Why?
|
| Databases, Genetic | 2 | 2018 | 1751 | 0.040 |
Why?
|
| Polyneuropathies | 1 | 2019 | 139 | 0.040 |
Why?
|
| Cerebral Revascularization | 1 | 2021 | 260 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2018 | 6853 | 0.040 |
Why?
|
| Pamphlets | 1 | 2018 | 71 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2003 | 2341 | 0.040 |
Why?
|
| Sleep Stages | 1 | 2022 | 698 | 0.040 |
Why?
|
| Kidney Function Tests | 1 | 2020 | 683 | 0.040 |
Why?
|
| Emotions | 2 | 2022 | 2763 | 0.040 |
Why?
|
| Gene Duplication | 1 | 2019 | 317 | 0.040 |
Why?
|
| Radiopharmaceuticals | 1 | 2007 | 2699 | 0.040 |
Why?
|
| Contrast Media | 2 | 2009 | 5329 | 0.040 |
Why?
|
| Spouses | 1 | 2020 | 288 | 0.040 |
Why?
|
| Cerebellum | 1 | 2025 | 1518 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2018 | 6014 | 0.030 |
Why?
|
| Australia | 1 | 2021 | 1258 | 0.030 |
Why?
|
| Anisotropy | 2 | 2014 | 1282 | 0.030 |
Why?
|
| Mortality | 2 | 2020 | 2904 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 2 | 2009 | 5526 | 0.030 |
Why?
|
| Withholding Treatment | 1 | 2021 | 621 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2018 | 268 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2019 | 490 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2019 | 437 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2009 | 1946 | 0.030 |
Why?
|
| Cancer Care Facilities | 1 | 2019 | 426 | 0.030 |
Why?
|
| Muscle Weakness | 1 | 2019 | 413 | 0.030 |
Why?
|
| Arteries | 2 | 2014 | 1118 | 0.030 |
Why?
|
| Antiporters | 1 | 2018 | 275 | 0.030 |
Why?
|
| Blood Component Transfusion | 1 | 2017 | 138 | 0.030 |
Why?
|
| Sports | 1 | 2022 | 698 | 0.030 |
Why?
|
| Emergency Medicine | 1 | 2005 | 1221 | 0.030 |
Why?
|
| Models, Biological | 1 | 2012 | 9443 | 0.030 |
Why?
|
| Occipital Lobe | 2 | 2008 | 376 | 0.030 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2018 | 320 | 0.030 |
Why?
|
| Gene Expression | 2 | 2019 | 7584 | 0.030 |
Why?
|
| Psychology | 1 | 2018 | 354 | 0.030 |
Why?
|
| Violence | 1 | 2022 | 935 | 0.030 |
Why?
|
| Edema | 1 | 2020 | 760 | 0.030 |
Why?
|
| Expert Testimony | 1 | 2017 | 266 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2021 | 2263 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2004 | 1393 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 10729 | 0.030 |
Why?
|
| Massachusetts | 2 | 2020 | 8875 | 0.030 |
Why?
|
| Reference Values | 2 | 2019 | 4908 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 2019 | 550 | 0.030 |
Why?
|
| Haiti | 1 | 1997 | 553 | 0.030 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2018 | 541 | 0.030 |
Why?
|
| Proteomics | 2 | 2023 | 3910 | 0.030 |
Why?
|
| Polysomnography | 1 | 2022 | 1859 | 0.030 |
Why?
|
| Longevity | 1 | 2023 | 1087 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2018 | 820 | 0.030 |
Why?
|
| Iodine | 1 | 2017 | 288 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 369 | 0.030 |
Why?
|
| Calibration | 1 | 2017 | 814 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2015 | 623 | 0.030 |
Why?
|
| Software | 3 | 2017 | 4462 | 0.030 |
Why?
|
| Computational Biology | 2 | 2018 | 3559 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2018 | 792 | 0.030 |
Why?
|
| Status Epilepticus | 1 | 2019 | 460 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2014 | 6203 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2018 | 670 | 0.030 |
Why?
|
| New Orleans | 1 | 2013 | 27 | 0.030 |
Why?
|
| Multilocus Sequence Typing | 1 | 2014 | 102 | 0.030 |
Why?
|
| Anger | 1 | 2016 | 402 | 0.030 |
Why?
|
| Population | 1 | 2014 | 140 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2023 | 2058 | 0.030 |
Why?
|
| RGS Proteins | 1 | 2013 | 75 | 0.030 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2018 | 669 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2014 | 23601 | 0.030 |
Why?
|
| Receptors, Oxytocin | 1 | 2013 | 71 | 0.030 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2013 | 88 | 0.030 |
Why?
|
| Health Behavior | 1 | 2024 | 2650 | 0.030 |
Why?
|
| Focus Groups | 1 | 2019 | 1459 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 9525 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2018 | 906 | 0.030 |
Why?
|
| Outpatients | 1 | 2021 | 1595 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 1997 | 1831 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2018 | 952 | 0.020 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2013 | 199 | 0.020 |
Why?
|
| Water-Electrolyte Balance | 1 | 2013 | 325 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2015 | 591 | 0.020 |
Why?
|
| Peripheral Arterial Disease | 1 | 2023 | 1311 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2018 | 834 | 0.020 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 7 | 1 | 2011 | 6 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2000 | 1995 | 0.020 |
Why?
|
| Entorhinal Cortex | 1 | 2014 | 285 | 0.020 |
Why?
|
| Automation | 1 | 2014 | 585 | 0.020 |
Why?
|
| Microcirculation | 2 | 2008 | 1280 | 0.020 |
Why?
|
| Calcium Channels, L-Type | 1 | 2013 | 242 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 12240 | 0.020 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2013 | 326 | 0.020 |
Why?
|
| Chromatin | 1 | 2023 | 2980 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 2014 | 606 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2020 | 2233 | 0.020 |
Why?
|
| Species Specificity | 1 | 2015 | 2406 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 1837 | 0.020 |
Why?
|
| Reference Standards | 1 | 2014 | 1013 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2022 | 2822 | 0.020 |
Why?
|
| Quality Control | 1 | 2014 | 837 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2016 | 1718 | 0.020 |
Why?
|
| Telomere | 1 | 2017 | 943 | 0.020 |
Why?
|
| Hospital Charges | 1 | 2012 | 345 | 0.020 |
Why?
|
| Biopsy | 2 | 2016 | 6763 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2015 | 866 | 0.020 |
Why?
|
| Morbidity | 1 | 2016 | 1749 | 0.020 |
Why?
|
| Head-Down Tilt | 1 | 2010 | 67 | 0.020 |
Why?
|
| Fungal Proteins | 1 | 1994 | 899 | 0.020 |
Why?
|
| Japan | 1 | 2014 | 1415 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2014 | 677 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1599 | 0.020 |
Why?
|
| Acoustic Impedance Tests | 1 | 2010 | 111 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2013 | 655 | 0.020 |
Why?
|
| Washington | 1 | 2010 | 314 | 0.020 |
Why?
|
| Unfolded Protein Response | 1 | 2011 | 239 | 0.020 |
Why?
|
| Infant | 3 | 2021 | 36386 | 0.020 |
Why?
|
| Acute Lung Injury | 1 | 2013 | 377 | 0.020 |
Why?
|
| Hippocampus | 2 | 2014 | 3775 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 1748 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2020 | 4184 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 17594 | 0.020 |
Why?
|
| Subdural Space | 1 | 2009 | 38 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 2780 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 6832 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 1994 | 1130 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2014 | 1158 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2022 | 4040 | 0.020 |
Why?
|
| Physician's Role | 1 | 2015 | 927 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2021 | 3564 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 2475 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2018 | 1587 | 0.020 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2010 | 262 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 1884 | 0.020 |
Why?
|
| Arterioles | 1 | 2009 | 251 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2012 | 1978 | 0.020 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2013 | 622 | 0.020 |
Why?
|
| Zebrafish Proteins | 1 | 2014 | 1018 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 1994 | 1999 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2019 | 3139 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2014 | 2243 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2015 | 1456 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2018 | 3561 | 0.020 |
Why?
|
| Executive Function | 1 | 2016 | 1391 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2010 | 752 | 0.020 |
Why?
|
| Ear, Middle | 1 | 2010 | 341 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2010 | 634 | 0.020 |
Why?
|
| Iceland | 1 | 2007 | 183 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2008 | 276 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2010 | 912 | 0.020 |
Why?
|
| Actins | 1 | 1994 | 2056 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2010 | 895 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 6220 | 0.020 |
Why?
|
| Hormones | 1 | 2010 | 863 | 0.020 |
Why?
|
| Pressure | 1 | 2010 | 1168 | 0.020 |
Why?
|
| Glycine | 1 | 2010 | 672 | 0.020 |
Why?
|
| Troponin I | 1 | 2011 | 655 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2007 | 6493 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2018 | 12131 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2019 | 3242 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2015 | 2589 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2014 | 1142 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 7425 | 0.020 |
Why?
|
| Dementia, Vascular | 1 | 2007 | 126 | 0.020 |
Why?
|
| Genome | 1 | 2014 | 1753 | 0.020 |
Why?
|
| Troponin T | 1 | 2011 | 785 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 2310 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 4137 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2011 | 975 | 0.020 |
Why?
|
| Half-Life | 1 | 2006 | 644 | 0.020 |
Why?
|
| North America | 1 | 2009 | 1285 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2880 | 0.020 |
Why?
|
| Learning | 1 | 2015 | 1755 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 7838 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2020 | 6424 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 7478 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2008 | 1381 | 0.010 |
Why?
|
| Canada | 1 | 2010 | 2119 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2012 | 5020 | 0.010 |
Why?
|
| Education | 1 | 2007 | 533 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3819 | 0.010 |
Why?
|
| Self Report | 1 | 2016 | 3770 | 0.010 |
Why?
|
| Plaque, Amyloid | 1 | 2008 | 772 | 0.010 |
Why?
|
| Mice | 3 | 2018 | 81819 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2010 | 12437 | 0.010 |
Why?
|
| Cytokines | 1 | 2019 | 7421 | 0.010 |
Why?
|
| Sweden | 1 | 2007 | 1381 | 0.010 |
Why?
|
| Nafcillin | 1 | 2004 | 23 | 0.010 |
Why?
|
| Middle Cerebral Artery | 1 | 2005 | 268 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3807 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2010 | 2721 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1994 | 2674 | 0.010 |
Why?
|
| Creatinine | 1 | 2009 | 1915 | 0.010 |
Why?
|
| Iatrogenic Disease | 1 | 2007 | 553 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2014 | 2858 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2008 | 1417 | 0.010 |
Why?
|
| Animals | 4 | 2018 | 168764 | 0.010 |
Why?
|
| Health Surveys | 1 | 2013 | 4056 | 0.010 |
Why?
|
| Zebrafish | 1 | 2014 | 3036 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 3529 | 0.010 |
Why?
|
| Metabolomics | 1 | 2012 | 1668 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2006 | 1638 | 0.010 |
Why?
|
| Skull | 1 | 2007 | 811 | 0.010 |
Why?
|
| Intracranial Thrombosis | 1 | 2003 | 109 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2012 | 2172 | 0.010 |
Why?
|
| Poverty | 1 | 2013 | 2714 | 0.010 |
Why?
|
| Age Distribution | 1 | 2007 | 2858 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2012 | 1938 | 0.010 |
Why?
|
| Point-of-Care Systems | 1 | 2010 | 1217 | 0.010 |
Why?
|
| Mitochondria | 1 | 1994 | 3673 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 2004 | 539 | 0.010 |
Why?
|
| Base Sequence | 1 | 2011 | 12403 | 0.010 |
Why?
|
| Vancomycin | 1 | 2004 | 504 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 9601 | 0.010 |
Why?
|
| Medical Records | 1 | 2006 | 1409 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2016 | 4416 | 0.010 |
Why?
|
| tau Proteins | 1 | 2010 | 2112 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2006 | 2352 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2013 | 42500 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2012 | 6255 | 0.010 |
Why?
|
| Headache | 1 | 2007 | 1259 | 0.010 |
Why?
|
| DNA | 1 | 2012 | 7202 | 0.010 |
Why?
|
| Cardiovascular Diseases | 2 | 2017 | 15652 | 0.010 |
Why?
|
| Smoking | 1 | 2014 | 9081 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2007 | 1808 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 22332 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2012 | 3458 | 0.010 |
Why?
|
| Aortic Aneurysm | 1 | 2000 | 623 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 6309 | 0.010 |
Why?
|
| Ultracentrifugation | 1 | 1994 | 155 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 2000 | 804 | 0.010 |
Why?
|
| Myosins | 1 | 1994 | 408 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2012 | 26346 | 0.010 |
Why?
|
| Thrombosis | 1 | 2005 | 2949 | 0.010 |
Why?
|
| Point Mutation | 1 | 1994 | 1590 | 0.000 |
Why?
|
| Protein Binding | 1 | 1994 | 9296 | 0.000 |
Why?
|